Helena Kuivaniemi

About

Helena Kuivaniemi is a pioneering molecular geneticist whose work has fundamentally advanced the understanding of heritable connective tissue disorders, most notably osteogenesis imperfecta (OI). Her research centers on the genetic basis of vascular and skeletal diseases, with a major focus on identifying mutations in the genes encoding type I procollagen. Kuivaniemi made landmark contributions by developing and implementing high-throughput DNA sequencing methodologies to screen for these mutations. She was among the first to apply robotic automation to dideoxyribonucleotide sequencing, creating a system capable of performing 240 reactions in a single unattended run—a transformative innovation that dramatically accelerated mutation discovery. Her 1996 paper, which used robotically automated sequencing of procollagen cDNAs, helped define more than 150 mutations in OI patients, particularly those with mild forms of the disease. While her individual citation counts for these early method papers are modest (18, 9, and 8 citations), their impact is profound: they laid the technical groundwork for modern DNA diagnostics. Kuivaniemi’s work bridged the gap between bench technology and clinical application, enabling the precise molecular characterization of heritable disorders and shaping the future of personalized genetic medicine.

Research Focus

Key Achievements

Top Papers

1. 1
   Direct sequencing of PCR products derived from cDNAs for the proα1 and proα2 chains of type I procollagen as a screening method to detect mutations in patients with osteogenesis imperfecta

   18 citations · 1996
2. 2
   Efficient DNA sequencing on microtiter plates using dried reagents and Bst DNA polymerase

   9 citations · 1993
3. 3
   Robotic automation of dideoxyribonucleotide sequencing reactions.

   8 citations · 1994
4. 4
   DNA-based diagnostics in the study of heritable and acquired disorders.

   7 citations · 1995

Key Collaborators

Contact & Links